American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

RSS icon
Thumbnail

COVID-19 caused CVD deaths in the U.S. to spike, new research confirms

Researchers explored updated data from the AHA, noting that the number of CVD-related deaths increased from more than 874,000 in 2019 to more than 928,000 in 2020.

Thumbnail

Why more pulmonary embolism patients should be considered for surgery

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

Thumbnail

AHA: ‘Mini strokes’ need emergency assessment, may require hospitalization

Even if symptoms disappear quickly, a transient ischemic attack can be a major short-term risk indicator.

Thumbnail

Intermittent fasting not associated with long-term weight loss, according to new 6-year analysis

Reducing total calorie intake and minimizing large meals, on the other hand, were both linked to improved weight loss. The study followed participants for an average of 6.3 years. 

Thumbnail

EHR intervention targets acute kidney injuries after PCI

Contrast-associated acute kidney injury is a significant problem in cardiology, especially among patients undergoing percutaneous coronary intervention. Can EHR-generated alerts make an impact?

Peter Libby, MD, a cardiovascular medicine specialist, Brigham and Women’s Hospital, and Mallinckrodt Professor of Medicine, Harvard Medical School, explains the take aways from the PROMINENT trial using pemafibrate to lower cardiovascular risks. The trial, presented at the American Heart Association (AHA) 2022 meeting, did not show reduction in the incidence of cardiovascular events among those who received pemafibrate than among those who received placebo. #AHA #AHA22

VIDEO: Pemafibrate does not lower cardiovascular risks in the PROMINENT trial

Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital and Harvard Medical School, explained some key takeaways from the PROMINENT trial.

The 120,000-square-foot advanced outpatient care center on the 4800 block of South Cottage Grove Avenue is expected to serve more than 50,000 patients annually from Bronzeville and nearby communities. Northwestern also wants to try and staff the majority of the clinic with clinicians who are Black to better reflect the community they will be serving. Construction could begin in summer 2023, with a scheduled opening in summer of 2025.

VIDEO: Northwestern plans to open Chicago South Side clinic to address healthcare access

Northwestern's Clyde Yancy, MD, discusses how his health system is addressing health access equity issues with plans to open a new outpatient clinic on the historically Black Chicago South Side.

Thumbnail

Elevated uric acid levels linked to new-onset AFib

According to new data published in the Journal of the American Heart Association, atrial fibrillation can be added to the list of cardiovascular conditions associated with above-average uric acid levels. 

Displaying 81 - 88 of 183

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.